Abstract
MS-209 is a novel quinoline compound which can overcome multidrug resistance (MDR) both in vitro and in vivo, while having a low level of side effects, and is now being evaluated in a clinical phase II study. Reverse transcription-polymerase chain reaction (RT-PCR) was used to quantitative the expression levels ofMDR genes in various mouse and human tumor cell lines. TheMDR gene and the βactin gene, as the internal reference standard, were coamplified separately, and the relative expression of theMDR gene was represented by the MDR/β actin ratio. The in vitro MDR-reversing effect of MS-209 was then compared with theMDR gene expression (MDR/β actin ratio). We found a significant correlation between these two parameters. Moreover, a significant correlation was also observed between the level of expression of theMDR1 gene and that of P-glycoprotein in human cell lines. Therefore, the efficacy of MS-209 seems to specifically depend on the level ofMDR gene expression (P-glycoprotein). From these observations, it is suggested that RT-PCR assays ofMDR1 gene in tumor biopsy specimens might be an effective means to predict the response of tumor cells to combination therapy with MS-209.
Similar content being viewed by others
Abbreviations
- MDR :
-
multidrug resistance
- ADM :
-
adriamycin
- VCR :
-
vincristine
- MTT :
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- RT :
-
reverse transcription
- PCR :
-
polymerase chain reaction,SDS sodium dodecyl sulfate
- PMSF :
-
phenylmethylsulfonyl fluoride
- EtBr :
-
ethidium bromide
- IC 50 :
-
concentration producing 50% inhibition
References
Alonso S, Minty A, Bourlet Y, Buckingham M (1986) Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23:11–22
Becker-André M, Hahlbrock K (1989) Absolute quantitation using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration asay (PATTY). Nucl Acids Res 17:9437–9446
Bremer S, Hoof T, Wilke M, Busche R, Scholte B, Riordan JR, Maass G, Tümmler B (1992) Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and diferentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. Eur J Biochem 206: 137–149
Carmichael JD, Degraff WG, Gazdar AF, Minna JD, Michell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936–942
Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in themdr 1 (P-glycoprotein), gene from multidrug-resistant human cells. Cell 47:381–389
Chin JE, Soffir R, Noonan KE, Choi K, Roninson IB (1989) Structure and expression of the humanMDR (P-glycoprotein) gene family. Mol Cell Biol 9:3808–3820
Chomeczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Endicott JA, Ling V (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58:137–171
Fukazawa N, Odate M, Suzuki T, Otsuka K, Sato W, Tsuruo T (1989) Novel heterocyclic compounds and anticancerdrug reinforcing agents containing them as effective components. European Patent Publication No. 0363212
Gilliland G, Perrin S, Blanchard K, Bunn HF (1990) Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725–2729
Gros P, Ben-Neriah Y, Croop J, Housman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323:728–731
Gros P, Croop J, Housman D (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371–380
Guillem JG, Levy MF, Hsieh LL, Johnson MD LoGerfo P, Forde KA, Weinstein IB (1990) Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer. Mol Carcinog 3:68–74
Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT (1992) Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. J Natl Cancer Inst 84:711–716
Higuchi R, Dollinger G, Walsh PS and Griffith R (1992) Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10:413–417
Hoof T, Riordan JR, Tümmler B (1991) Quantitation of mRNA by the kinetic polymerase chain reaction assay: a tool for monitoring P-glycoprotein gene expression. Anal Biochem 196:161–169
Horikoshi T, Danenberg, KD, Stadlbauer THW, Volkenandt M, Shea LCC, Aigner K, Gustavsson B, Leichman L, Frösing R, Ray M, Gibson NW, Spears CP, Danenberg PV (1992) Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52:108–116
Hsu SI-H, Lothstein L, Horwitz SB (1989) Differential overexpression of threemdr gene family members in multidrug resistant J774.2 mouse cells. J Biol Chem 264:12053–12062
Hsu SI-H, Cohen D, Kirschner LS, Lothstein L, Hartstein M, Horwitz SB (1990) Structural analysis of the mousemdr 1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells. Mol Cell Bio 10:3596–3606
Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE (1990) Use of the polymerase chain reaction in the quantitation ofmdr-1 gene expression. Biochemistry 29:10351–10356
Naito M, Hamada H, Tsuruo T (1988) ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. J Biol Chem 263:11887–11891
Ng WF, Sarangi F, Zastawny RL, Veinot-Drebot L, Ling V (1988) Identification of members of the P-glycoprotein multigene family. Mol. Cell Biol 9:1224–1232
Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AE, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis ofMDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160–7164
Ponte P, Ng SY, Engel J, Gunning P, Kedes L (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucl Acids Res 12:1687–1696
Ruetz S, Gros P (1994) Phosphatidylcholine translocase: a physiological role for themdr 2 gene. Cell 77:1071–1081
Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T (1991) Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073. Cancer Res 51:2420–2424
Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T (1995) Reversal of multidrug resistance by a novel quinoline derivative, MS-209. Cancer Chemother Pharmacol 35:271–277
Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM, Borst P (1993) Homozygous disruption of the murinemdr 2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451–462
Tsuruo T (1989) Circumvention of drug resistance with calcium channel blockers and monoclonal antibodies. In: Ozols RF (ed) Drug resistance in cancer therapy. Kluwer, Boston, pp 73–95
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) Increased accumulation of vincristine and adriamycin in drug-resistant tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42:4730–4733
Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43: 2905–2910
Tsuruo T, Iida H, Ohkochi E, Tsukagoshi S, Sakurai Y (1983) Establishment and properties of vincristine-resistant human myelogenous leukemia K562. Gann 74:751–758
Tsuruo T, Iida H, Kikatani Y., Yokota K, Tsukagoshi S, Sakurai Y (1984) Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 44: 4303–4307
Tsuruo T, Iida-Saito H, Kawabata H, Oh-Hara T, Hamada H, Utakoji T (1986) Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn J Cancer Res 77:682–692
Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for the human “MDRI” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004–3008
Wang AM, Doyle MV, Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86: 9717–9721
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baba, M., Nakanishi, O., Sato, W. et al. Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells. Cancer Chemother. Pharmacol. 36, 361–367 (1995). https://doi.org/10.1007/BF00686183
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686183